Details for New Drug Application (NDA): 062333
NDA 062333 describes MEZLIN, which is a drug marketed by Bayer Pharms and is included in four NDAs. Additional details are available on the MEZLIN profile page.
The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. There is one drug master file entry for this compound. Additional details are available on the mezlocillin sodium monohydrate profile page.
The generic ingredient in MEZLIN is mezlocillin sodium monohydrate. There is one drug master file entry for this compound. Additional details are available on the mezlocillin sodium monohydrate profile page.
Summary for 062333
| Tradename: | MEZLIN |
| Applicant: | Bayer Pharms |
| Ingredient: | mezlocillin sodium monohydrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062333
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 3GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
